Merck (MRK) stock merits your attention. Why? Because it offers monopoly-like high margins at a discounted price. Here are some statistics.Revenue Growth: Merck experienced growth of 1.8% LTM and 3.7% over the last 3 years on average.Recent Profitability: Approximately 29.1% operating cash flow margin and 31.2% operating margin LTM.Long-Term Profitability: About 27.2% operating cash flow margin and 22.6% operating margin for the last 3 years on average.Available At Discount: At a P/S multiple of 3.5, MRK st ...

Photo illustration by Cheng Xin/Getty ImagesGetty ImagesEli Lilly (LLY) stock merits your attention. Why? Because it offers monopoly-like high margins at a reduced price. Here is some data.Revenue Growth: Eli Lilly experienced a growth of 36.8% LTM and an average of 23.4% over the last 3 years.Recent Profitability: Approximately 20.5% operating cash flow margin and 43.0% operating margin LTM.Long-Term Profitability: Roughly 17.8% operating cash flow margin and a 35.6% operating margin average over the last ...